The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.20
Ask: 65.40
Change: 0.80 (1.25%)
Spread: 2.20 (3.481%)
Open: 63.20
High: 65.00
Low: 63.20
Prev. Close: 64.20
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results update

16 Mar 2020 07:00

RNS Number : 1909G
IDOX PLC
16 March 2020
 

16 March 2020

Idox plc

('Idox' or the 'Group' or the 'Company')

FY20 Q1 Trading Update

Dividend Update

FY19 Trading Update

Notice of Results

 

ldox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, is pleased to issue a trading update for the first quarter of its financial year ending 31 October 2020 ("FY20"). 

Highlights in the first quarter of FY20 include:

· Significantly stronger financial performance with improved revenues and earnings compared to the same period last year:

o Q1 financial performance is consistent with the Board's expectations for FY20 as a whole.

· Material reduction in closing net debt as at 31 January 2020 at £27.5m (FY19: £35.5m) representing leverage* of below 1.6 times, underpinning a much stronger financial position.

· The Group continues to make good strategic and commercial progress across the business; our Tascomi business acquired in August 2019 is integrating well and is performing as planned.

· All historical issues identified in FY19 have been fully resolved: Idox entered FY20 with no material remaining outstanding litigation or property issues. All non-core businesses have been disposed, and new financial reporting and operational controls are now fully embedded throughout the Group.

· The Board intends to introduce a final dividend in respect of FY20 which it anticipates will be approximately 30% of retained earnings.

In summary, we are progressing well against our plans for FY20 and remain encouraged by the opportunities; the Board remains confident in the prospects of the business for FY20 and beyond.

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition, corporate finance and share option costs.

* Net debt / trailing 12 months Adjusted EBITDA

 

FY19 Trading Update

Further to the Trading Update the on FY19 the Group provided on 25 November 2019, the Group expects to report the following results for its financial year ended 31 October 2019:

Financial highlights:

· Revenue of £65.5m (2018: £66.4m for continuing business, restated for prior year adjustments).

· Revenue visibility significantly improved, with annualised recurring revenue run rate at 31 October 2019 up 20% to £38.9m following adoption of IFRS 15 (16% organic).

· Contracted software and services order book up 29% to £12.1m.

· Adjusted EBITDA: £14.4m (2018: £13.6m, restated) for continuing business.

· Net debt at 31 October 2019 down 17% at £26.4m (2018: £31.8m).

· Statutory loss before tax £0.03m (2018: £27.6m loss, restated) for continuing operations.

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

Notice of Results

The Group continues to work closely with its auditor to resolve an outstanding historical matter that has arisen on finalisation of its FY19 results in respect of the FY17 financial reporting period, associated with the acquisition of 6PM Holdings plc. This remaining item does not have any impact on the Group's expected FY19 results or its future prospects.

The Group expects to resolve the matter shortly, and expects to issue its FY19 results announcement as soon as practical.

 

Statement on Covid-19

The Group has considered the impact of the ongoing Covid-19 pandemic. The Board believes Idox is well placed because of the Group's high recurring revenue base, the high proportion of staff that work from home, and the limited exposure to the geographies currently most impacted by the virus. We continue to monitor the situation and adapt our approach as required.

The exposures identified to date are as follows:

· our EIM Business has cross-border operations; any impact is tempered by its existing high recurring revenues which account for approximately 80% of its revenue targets;

· our Public Sector Software business is exposed to government policy in response to Covid-19, notably the recent postponement of the local and mayoral elections originally scheduled for May 2020 to May 2021;

· overall, no material impact has been identified to date.

We continue to update our contingency planning and risk assessments in respect of Covid-19 as the impact of the virus develops.

 

David Meaden, Chief Executive of Idox, commented:

"We entered FY20 with encouraging momentum following the extensive reform of the business in the previous year and it is therefore pleasing to report a strong first quarter performance, consistent with our expectations.

The business is benefitting from our strategy to significantly increase engagement with our customers, staff and other stakeholders and from the introduction of new products and extended service offerings. During FY20, we are planning further integration of our activities and refinement of our operating models to drive further efficiencies.

We are pleased with the progress we have made but are not complacent. We remain committed to establishing Idox as a leader in Public Sector Software with market-leading cloud-based products and an efficient operating model to drive high levels of recurring revenue, strong margins and consistent cash generation."

 

 

-Ends-

 

Enquiries:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Edward Knight

Nick Prowting

James Steel

 

 

MHP Communications

+ 44 (0) 203 128 8100

 

Reg Hoare `

 idox@mhpc.com

 

Patrick Hanrahan

 

Amy O'Sullivan

 

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUVUORRNUOAUR
Date   Source Headline
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company
30th Aug 20198:18 amRNSHolding(s) in Company
30th Aug 20198:16 amRNSHolding(s) in Company
30th Aug 20197:00 amRNSDirectors' Dealings & Holdings in Company
20th Aug 20199:20 amRNSHolding(s) in Company
9th Aug 20193:16 pmRNSCompletion of Acquisition of Tascomi Ltd
8th Aug 201910:56 amRNSHolding(s) in Company
6th Aug 20198:06 amRNSDirectors' Dealings & Holdings in Company
31st Jul 201910:30 amRNSFurther Details on the Fundraising
31st Jul 20197:00 amRNSProposed Fundraising via accelerated bookbuild
22nd Jul 20197:00 amRNSHalf-year Report
4th Apr 20194:17 pmRNSDirector/PDMR Share Dealing
3rd Apr 20197:00 amRNSBoard Change
29th Mar 20191:08 pmRNSResult of AGM
29th Mar 20197:00 amRNSAGM Trading Update & 2016 Prior Year Adjustment
22nd Mar 20197:00 amRNSDirectorate Change
18th Mar 20195:16 pmRNSOption Awards
12th Mar 20193:17 pmRNSDirector Dealings and Option Awards
7th Mar 20191:29 pmRNSPosting of Annual Report and Notice of AGM
21st Feb 20197:00 amRNSFinal Results for the year ended 31 October 2018
20th Feb 20192:13 pmRNSExercise of Share Options & Total Voting Rights
1st Feb 20198:20 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSExtension of Banking Facilities
22nd Jan 20198:24 amRNSHolding(s) in Company
7th Jan 20192:50 pmRNSBoard Change
27th Nov 20187:00 amRNSYear End Trading Update
22nd Nov 20187:00 amRNSDirectorate Change
19th Nov 20187:00 amRNSDirectorate Change
5th Nov 20187:00 amRNSDisposal of Digital division
31st Oct 20187:00 amRNSDirectorate Change
25th Oct 20183:23 pmRNSHolding(s) in Company
19th Oct 20185:01 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSAppointment of Chief Financial Officer
12th Sep 20183:46 pmRNSHolding(s) in Company
10th Sep 201811:22 amRNSExercise of Share Options & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.